Editas Medicine, Inc.
Biological Products, (No Diagnostic Substances) · 11 HURLEY ST., CAMBRIDGE, MA 02141
官方登记数据
0位关注者
2013成立于
关于 Editas Medicine, Inc.
Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.
Source: Wikipedia
行业Biological Products, (No Diagnostic Substances)
总部11 HURLEY ST., CAMBRIDGE, MA 02141
成立2013
法律形式C Corporation
状态营业中
专利593 项专利
CRISPR-RELATED METHODS AND COMPOSITIONS TARGETING FL1-1 EXPRESSIONUS20260241033A1 · 2026
CRISPR-RELATED METHODS AND COMPOSITIONS TARGETING LOW-DENSITY LIPOPROTEIN RECEPTOR (LDLR)US20260242779A1 · 2026
关键数据
法律信息
| 法定名称 | Editas Medicine, Inc. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1650664在 SEC EDGAR 上查看 ↗ |
| EIN | 46-4097528 |
| 行业代码(SIC) | 2836 |
| 注册地址 | 11 HURLEY ST., CAMBRIDGE, MA 02141 |
| 状态 | 营业中 |
来源: SEC EDGAR · 更新于 Oct. 15, 2026